213 related articles for article (PubMed ID: 27124054)
1. Diagnostic Performance of Fused Diffusion-Weighted Imaging Using Unenhanced or Postcontrast T1-Weighted MR Imaging in Patients With Breast Cancer.
Shin HJ; Chae EY; Choi WJ; Ha SM; Park JY; Shin KC; Cha JH; Kim HH
Medicine (Baltimore); 2016 Apr; 95(17):e3502. PubMed ID: 27124054
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
[TBL] [Abstract][Full Text] [Related]
4. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a known breast cancer using an abbreviated breast MRI protocol: Correlation of imaging characteristics and pathology with lesion detection and conspicuity.
Heacock L; Melsaether AN; Heller SL; Gao Y; Pysarenko KM; Babb JS; Kim SG; Moy L
Eur J Radiol; 2016 Apr; 85(4):815-23. PubMed ID: 26971429
[TBL] [Abstract][Full Text] [Related]
6. Analysis of factors influencing the degree of detectability on diffusion-weighted MRI and diffusion background signals in patients with invasive breast cancer.
Hahn SY; Ko ES; Han BK; Lim Y; Gu S; Ko EY
Medicine (Baltimore); 2016 Jul; 95(27):e4086. PubMed ID: 27399100
[TBL] [Abstract][Full Text] [Related]
7. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
[TBL] [Abstract][Full Text] [Related]
8. Abbreviated screening protocol for breast MRI: a feasibility study.
Grimm LJ; Soo MS; Yoon S; Kim C; Ghate SV; Johnson KS
Acad Radiol; 2015 Sep; 22(9):1157-62. PubMed ID: 26152500
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
[TBL] [Abstract][Full Text] [Related]
10. Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T.
Bogner W; Pinker K; Zaric O; Baltzer P; Minarikova L; Porter D; Bago-Horvath Z; Dubsky P; Helbich TH; Trattnig S; Gruber S
Radiology; 2015 Jan; 274(1):74-84. PubMed ID: 25341078
[TBL] [Abstract][Full Text] [Related]
11. Unenhanced magnetic resonance screening using fused diffusion-weighted imaging and maximum-intensity projection in patients with a personal history of breast cancer: role of fused DWI for postoperative screening.
Kang JW; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH
Breast Cancer Res Treat; 2017 Aug; 165(1):119-128. PubMed ID: 28577079
[TBL] [Abstract][Full Text] [Related]
12. Independent value of image fusion in unenhanced breast MRI using diffusion-weighted and morphological T2-weighted images for lesion characterization in patients with recently detected BI-RADS 4/5 x-ray mammography findings.
Bickelhaupt S; Tesdorff J; Laun FB; Kuder TA; Lederer W; Teiner S; Maier-Hein K; Daniel H; Stieber A; Delorme S; Schlemmer HP
Eur Radiol; 2017 Feb; 27(2):562-569. PubMed ID: 27193776
[TBL] [Abstract][Full Text] [Related]
13. Preoperative assessment of breast cancer: Multireader comparison of contrast-enhanced MRI versus the combination of unenhanced MRI and digital breast tomosynthesis.
Girometti R; Marconi V; Linda A; Di Mico L; Bondini F; Zuiani C; Sardanelli F
Breast; 2020 Feb; 49():174-182. PubMed ID: 31838292
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted MRI at 3.0 T for detection of occult disease in the contralateral breast in women with newly diagnosed breast cancer.
Ha SM; Chang JM; Lee SH; Kim ES; Kim SY; Cho N; Moon WK
Breast Cancer Res Treat; 2020 Jul; 182(2):283-297. PubMed ID: 32447596
[TBL] [Abstract][Full Text] [Related]
15. Breast lesion characterization using whole-lesion histogram analysis with stretched-exponential diffusion model.
Liu C; Wang K; Li X; Zhang J; Ding J; Spuhler K; Duong T; Liang C; Huang C
J Magn Reson Imaging; 2018 Jun; 47(6):1701-1710. PubMed ID: 29165847
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.
Zhou J; Chen E; Xu H; Ye Q; Li J; Ye S; Cheng Q; Zhao L; Su MY; Wang M
J Magn Reson Imaging; 2019 Jun; 49(6):1610-1616. PubMed ID: 30328211
[TBL] [Abstract][Full Text] [Related]
17. Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI.
Wengert GJ; Pipan F; Almohanna J; Bickel H; Polanec S; Kapetas P; Clauser P; Pinker K; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Mar; 30(3):1451-1459. PubMed ID: 31797077
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of malignant and benign breast lesions: Added value of the qualitative analysis of breast lesions on diffusion-weighted imaging (DWI) using readout-segmented echo-planar imaging at 3.0 T.
An YY; Kim SH; Kang BJ
PLoS One; 2017; 12(3):e0174681. PubMed ID: 28358833
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracy.
Spick C; Bickel H; Pinker K; Bernathova M; Kapetas P; Woitek R; Clauser P; Polanec SH; Rudas M; Bartsch R; Helbich TH; Baltzer PA
NMR Biomed; 2016 Oct; 29(10):1445-53. PubMed ID: 27553252
[TBL] [Abstract][Full Text] [Related]
20. In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.
Rahbar H; Partridge SC; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
Radiology; 2012 May; 263(2):374-82. PubMed ID: 22517955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
